M
Momenta Pharmaceuticals
Biotechnology company specializing in the characterization and process engineering of complex molecules
At a glance
- Status
- Listed
- Listing
- IPO 2004
News
Open roles
Momenta Pharmaceuticals in the Cambridge ecosystem
The Momenta Pharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Series B and later5 investors entered at this stage
- MPMVM Life Science Partners
- MVMithra Ventures
- CPCardinal Partners
Atlas Venture- MTMassachusetts Institute of Technology
Source: Dealroom Talent Intelligence.
Alumni founders
Former Momenta Pharmaceuticals employees who went on to found companies, sorted by Dealroom signal score.
VIVisterraEst. 2007
Ram SasisekharanUnited States
MBMitra BiotechEst. 2009
STSunflower TherapeuticsEst. 2018
Kathryn GoldenUnited States
AFAffinivaxEst. 2014
Steven BruggerUnited States
OVOvaScienceEst. 2011
Christoph WestphalUnited StatesPatents
58 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
See Momenta Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


